| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 25 |
| 1 | ASPIRIN 325 MG | 25 |
| 2 | ASPIRIN 81 MG | 25 |
| 3 | ROSUVASTATIN | 25 |
| 4 | ATORVASTATIN CALCIUM | 18 |
| 5 | LORLATINIB | 17 |
| 6 | ERGOCALCIFEROL | 15 |
| 7 | EVOLOCUMAB | 15 |
| 8 | GABAPENTIN | 14 |
| 9 | PREDNISONE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOMITAPIDE MESYLATE | 9 | 0.0024 |
| 1 | LORLATINIB | 17 | 0.0023 |
| 2 | ARTIFICIAL TEARS | 3 | 0.0011 |
| 3 | POLYVINYL ALCOHOL, POVIDONE | 3 | 0.0011 |
| 4 | TEPROTUMUMAB | 6 | 0.0010 |
| 5 | PEGVISOMANT | 4 | 0.0010 |
| 6 | INCLISIRAN | 7 | 0.0008 |
| 7 | ERGOCALCIFEROL | 15 | 0.0005 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 9 | ICOSAPENT ETHYL | 3 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 1 | Corticosteroid [EPC] | 26 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 25 |
| 3 | Benzodiazepine [EPC] | 22 |
| 4 | Kinase Inhibitor [EPC] | 22 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 21 |
| 6 | Atypical Antipsychotic [EPC] | 20 |
| 7 | beta-Adrenergic Blocker [EPC] | 19 |
| 8 | PCSK9 Inhibitor [EPC] | 18 |
| 9 | Thiazide Diuretic [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 6 | 0.0010 |
| 1 | Plasma Volume Expander [EPC] | 3 | 0.0010 |
| 2 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 3 | PCSK9 Inhibitor [EPC] | 18 | 0.0007 |
| 4 | Pyrethroid [EPC] | 1 | 0.0006 |
| 5 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 6 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 7 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 8 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |